Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

KalVista Pharmaceuticals (KALV) Return on Capital Employed (2017 - 2024)

KalVista Pharmaceuticals' Return on Capital Employed history spans 8 years, with the latest figure at 1.06% for Q4 2024.

  • For Q4 2024, Return on Capital Employed fell 42.0% year-over-year to 1.06%; the TTM value through Oct 2024 reached 1.06%, down 42.0%, while the annual FY2020 figure was 0.42%, 0.0% changed from the prior year.
  • Return on Capital Employed for Q4 2024 was 1.06% at KalVista Pharmaceuticals, down from 0.78% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.44% in Q1 2020 and bottomed at 1.06% in Q4 2024.
  • The 4-year median for Return on Capital Employed is 0.7% (2020), against an average of 0.72%.
  • The largest YoY upside for Return on Capital Employed was -8bps in 2024 against a maximum downside of -42bps in 2024.
  • A 4-year view of Return on Capital Employed shows it stood at 0.7% in 2020, then dropped by -9bps to 0.76% in 2021, then rose by 16bps to 0.64% in 2023, then plummeted by -65bps to 1.06% in 2024.
  • Per Business Quant, the three most recent readings for KALV's Return on Capital Employed are 1.06% (Q4 2024), 0.78% (Q3 2024), and 0.9% (Q2 2024).